⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCS News
Oculis Holding AG Ordinary shares
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
globenewswire.com
OCS
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
globenewswire.com
OCS
Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting
globenewswire.com
OCS
Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting
globenewswire.com
OCS
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
globenewswire.com
OCS
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
globenewswire.com
OCS
Oculis Publishes Invitation to the Annual General Meeting
globenewswire.com
OCS
Oculis Publishes Invitation to the Annual General Meeting
globenewswire.com
OCS
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
globenewswire.com
OCS
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
globenewswire.com
OCS